Jeffery S Larson

Title: Jeffery S Larson: Innovator in RRP Protein Research

Introduction

Jeffery S Larson is a notable inventor based in Burlingame, California. He has made significant contributions to the field of biotechnology, particularly in the study of rhomboid-related proteins (RRPs) and their implications in cancer research. His work focuses on the modulation of the EGFR signaling pathway, which is crucial for understanding tumor growth.

Latest Patents

Jeffery S Larson holds a patent titled "Human RRP sequences and methods of use." This patent involves the provision of rhomboid-related proteins that play a role in the EGFR signaling pathway. The patent describes transgenic, nonhuman mammals that contain a transgene encoding an RRP polypeptide. It also outlines methods for modulating the interaction of RRP proteins with their pathway members. Furthermore, the patent includes techniques for screening agents that can modulate the interaction of RRP polypeptides with specific binding targets, such as RRP-specific antibodies and small molecules identified through high throughput screens. The modulating agents identified can be utilized to inhibit the growth of tumor cells that overexpress RRP proteins.

Career Highlights

Jeffery S Larson is currently associated with Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His work at Exelixis has allowed him to contribute to groundbreaking research in the field of oncology.

Collaborations

Throughout his career, Jeffery has collaborated with esteemed colleagues, including Mario N Lioubin and Lori Friedman. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Jeffery S Larson's contributions to the understanding of rhomboid-related proteins and their role in cancer research highlight his importance as an inventor in the biotechnology sector. His patent work and collaborations continue to pave the way for advancements in cancer therapies.